Isabel Aznarez, Ph.D.

Co-Founder and Group VP,
Discovery Research

LinkedIn

Isabel Aznarez is a co-founder and group vice president of Discovery Research at Stoke Therapeutics. Isabel has extensive experience in human genetics, RNA metabolism and modulation of RNA processes using antisense oligonucleotides. Prior to founding Stoke Therapeutics, she was a research investigator with Professor Adrian Krainer, whose lab she joined as a postdoctoral fellow in 2008. Previously, Isabel was a researcher at the Hospital for Sick Children with Professor Lap-Chee Tsui, where she focused on the effect of cystic fibrosis mutations on the splicing of the CFTR gene. Isabel holds a Ph.D. in molecular and medical genetics from the University of Toronto and a B.Sc. in biology and human genetics from the University of Uruguay.

Articles and Accolades

BeLatina: Powered by Latinas: the Tech Giants You Need to Know

These Latina founders are changing the landscape of the tech world and breaking funding records, all while using personal experience, grit, and community to reach their dreams while impacting the world.

Stoked and Grateful: Published on LinkedIn, December 2020

Stoke's co-founder Isabel Asznarez reflects on the many things she's grateful for – doing what she loves, surrounded by colleagues she respects, and who are 100% committed to advancing science that may help people living with severe genetic diseases.